185 related articles for article (PubMed ID: 32536822)
21. Upregulation of MicroRNA-937 Predicts a Poor Prognosis and Promotes Hepatocellular Carcinoma Cell Proliferation, Migration, and Invasion.
Chen Z; Zhang Y
Mol Biotechnol; 2022 Jan; 64(1):33-41. PubMed ID: 34519997
[TBL] [Abstract][Full Text] [Related]
22. Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer.
Zhang Y; Jiang F; He H; Ye J; Mao X; Guo Q; Wu SL; Zhong W; Wu CL; Lin N
Cell Death Dis; 2018 Feb; 9(3):301. PubMed ID: 29467540
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of serum miR-768-3p in HBV-related hepatocellular carcinoma and its potential mechanism.
Cao C; Wang C
Clin Exp Med; 2020 Nov; 20(4):569-576. PubMed ID: 32712720
[TBL] [Abstract][Full Text] [Related]
24. Dysregulation of miR-3607 predicts prognosis of hepatocellular carcinoma and regulates tumor cell proliferation, migration and invasion.
Dou W; Yang M; Su Y; Xie R
Diagn Pathol; 2020 May; 15(1):54. PubMed ID: 32404179
[TBL] [Abstract][Full Text] [Related]
25. Upregulation of microRNA miR-652-3p is a prognostic risk factor for hepatocellular carcinoma and regulates cell proliferation, migration, and invasion.
Chi X; Jiang Y; Chen Y; Lv L; Chen J; Yang F; Zhang X; Pan F; Cai Q
Bioengineered; 2021 Dec; 12(1):7519-7528. PubMed ID: 34608826
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
[TBL] [Abstract][Full Text] [Related]
27. RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma.
Peng H; Du X; Zhang Y
Front Mol Biosci; 2022; 9():898567. PubMed ID: 35720121
[No Abstract] [Full Text] [Related]
28. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1.
Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL
J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of CISD1 Predicts Worse Survival in Hepatocarcinoma Patients.
Lu T; Li C; Xiang C; Gong Y; Peng W; Chen C
Biomed Res Int; 2022; 2022():7823191. PubMed ID: 35313629
[TBL] [Abstract][Full Text] [Related]
30. The upregulation of
Cui Z; Wang J; Chen G; Li D; Cheng B; Lai Y; Wu Z
Front Oncol; 2022; 12():1081510. PubMed ID: 36698420
[TBL] [Abstract][Full Text] [Related]
31. MiR-20b-5p promotes hepatocellular carcinoma cell proliferation, migration and invasion by down-regulating CPEB3.
Li Z; Wu L; Tan W; Zhang K; Lin Q; Zhu J; Tu C; Lv X; Jiang C
Ann Hepatol; 2021; 23():100345. PubMed ID: 33812045
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
33. Hypoxia-Induced Placenta-Specific microRNA (miR-512-3p) Promotes Hepatocellular Carcinoma Progression by Targeting Large Tumor Suppressor Kinase 2.
Zhang B; Huang L; Tu J; Wu T
Onco Targets Ther; 2020; 13():6073-6083. PubMed ID: 32612368
[TBL] [Abstract][Full Text] [Related]
34. Increased long noncoding RNA LINC00511 is correlated with poor prognosis and contributes to cell proliferation and metastasis by modulating miR-424 in hepatocellular carcinoma.
Wang RP; Jiang J; Jiang T; Wang Y; Chen LX
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3291-3301. PubMed ID: 31081082
[TBL] [Abstract][Full Text] [Related]
35.
Lin T; Zhang Y; Lin Z; Peng L
Int J Gen Med; 2021; 14():7487-7501. PubMed ID: 34744456
[TBL] [Abstract][Full Text] [Related]
36. miR-3677-5p promotes the proliferation, migration and invasion of hepatocellular carcinoma cells and is associated with prognosis.
Mao HX; Chen BW; Wang J; Ma CY; Gan YC; Qiu KJ
Exp Ther Med; 2021 Jul; 22(1):780. PubMed ID: 34055079
[TBL] [Abstract][Full Text] [Related]
37. LINC00265 Promotes Metastasis and Progression of Hepatocellular Carcinoma by Interacting with E2F1 at The Promoter of
Ge B; Zhang X; Zhou W; Mo Y; Su ZH; Xu G; Chen Q
Cell J; 2022 Jun; 24(6):294-301. PubMed ID: 35892231
[TBL] [Abstract][Full Text] [Related]
38. N6-Methyladenosine Modification and Prognostic Analysis of UBE2K in Hepatocellular Carcinoma: A Potential Target.
Guo J; Zhao J
Crit Rev Eukaryot Gene Expr; 2023; 33(8):41-55. PubMed ID: 37606163
[TBL] [Abstract][Full Text] [Related]
39. Cell division cycle associated 8: A novel diagnostic and prognostic biomarker for hepatocellular carcinoma.
Cui XH; Peng QJ; Li RZ; Lyu XJ; Zhu CF; Qin XH
J Cell Mol Med; 2021 Dec; 25(24):11097-11112. PubMed ID: 34741389
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma.
Jiang J; Liu B; Liu R; Yang W
Cancer Manag Res; 2021; 13():2517-2537. PubMed ID: 33758547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
